240 related articles for article (PubMed ID: 14501648)
1. Alpha blocker therapy for children with dysfunctional voiding and urinary retention.
Cain MP; Wu SD; Austin PF; Herndon CD; Rink RC
J Urol; 2003 Oct; 170(4 Pt 2):1514-5; discussion 1516-7. PubMed ID: 14501648
[TBL] [Abstract][Full Text] [Related]
2. Can alpha-blocker therapy be an alternative to biofeedback for dysfunctional voiding and urinary retention? A prospective study.
Yucel S; Akkaya E; Guntekin E; Kukul E; Akman S; Melikoglu M; Baykara M
J Urol; 2005 Oct; 174(4 Pt 2):1612-5; discussion 1615. PubMed ID: 16148665
[TBL] [Abstract][Full Text] [Related]
3. An Evaluation of the Efficacy of Selective Alpha-Blockers in the Treatment of Children with Neurogenic Bladder Dysfunction--Preliminary Findings.
Kroll P; Gajewska E; Zachwieja J; Sobieska M; Mańkowski P
Int J Environ Res Public Health; 2016 Mar; 13(3):. PubMed ID: 26999168
[TBL] [Abstract][Full Text] [Related]
4. alpha-Adrenergic blockade in children with neuropathic and nonneuropathic voiding dysfunction.
Austin PF; Homsy YL; Masel JL; Cain MP; Casale AJ; Rink RC
J Urol; 1999 Sep; 162(3 Pt 2):1064-7. PubMed ID: 10458432
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness of alpha1-adrenergic blockers in boys with low urinary flow rate and urinary incontinence.
Yang SS; Wang CC; Chen YT
J Formos Med Assoc; 2003 Aug; 102(8):551-5. PubMed ID: 14569320
[TBL] [Abstract][Full Text] [Related]
6. Effect of tamsulosin on systemic blood pressure and nonneurogenic dysfunctional voiding in children.
Vanderbrink BA; Gitlin J; Toro S; Palmer LS
J Urol; 2009 Feb; 181(2):817-22; discussion 822. PubMed ID: 19110267
[TBL] [Abstract][Full Text] [Related]
7. Double-blind placebo controlled study of alpha-adrenergic receptor antagonists (doxazosin) for treatment of voiding dysfunction in the pediatric population.
Kramer SA; Rathbun SR; Elkins D; Karnes RJ; Husmann DA
J Urol; 2005 Jun; 173(6):2121-4; discussion 2124. PubMed ID: 15879863
[TBL] [Abstract][Full Text] [Related]
8. Primary bladder neck dysfunction in children and adolescents II: results of treatment with alpha-adrenergic antagonists.
Donohoe JM; Combs AJ; Glassberg KI
J Urol; 2005 Jan; 173(1):212-6. PubMed ID: 15592078
[TBL] [Abstract][Full Text] [Related]
9. The effectiveness of transcutaneous electrical neural stimulation therapy in patients with urinary incontinence resistant to initial medical treatment or biofeedback.
Tugtepe H; Thomas DT; Ergun R; Kalyoncu A; Kaynak A; Kastarli C; Dagli TE
J Pediatr Urol; 2015 Jun; 11(3):137.e1-5. PubMed ID: 25824876
[TBL] [Abstract][Full Text] [Related]
10. Prospective study comparing hyoscyamine, doxazosin, and combination therapy for the treatment of urgency and frequency in women.
Serels S; Stein M
Neurourol Urodyn; 1998; 17(1):31-6. PubMed ID: 9453690
[TBL] [Abstract][Full Text] [Related]
11. [The comparative study on selective alpha1-blocker and behavioural therapy in the treatment of discoordinated voiding in children].
Kroll P; Jankowski A; Maćkowiak J
Przegl Lek; 2006; 63 Suppl 3():226-8. PubMed ID: 16898538
[TBL] [Abstract][Full Text] [Related]
12. Initial combined treatment with anticholinergics and α-blockers for men with lower urinary tract symptoms related to BPH and overactive bladder: a prospective, randomized, multi-center, double-blind, placebo-controlled study.
Lee SH; Chung BH; Kim SJ; Kim JH; Kim JC; Lee JY
Prostate Cancer Prostatic Dis; 2011 Dec; 14(4):320-5. PubMed ID: 21788967
[TBL] [Abstract][Full Text] [Related]
13. The use of botulinum toxin A injection for the management of external sphincter dyssynergia in neurologically normal children.
Franco I; Landau-Dyer L; Isom-Batz G; Collett T; Reda EF
J Urol; 2007 Oct; 178(4 Pt 2):1775-9; discussion 1779-80. PubMed ID: 17707430
[TBL] [Abstract][Full Text] [Related]
14. Improvement of urethral resistance after the administration of an alpha-adrenoceptor blocking agent, urapidil, for neuropathic voiding dysfunction.
Yamanishi T; Yasuda K; Tojo M; Hattori T; Sakakibara R; Shimazaki J
Paraplegia; 1994 Apr; 32(4):271-6. PubMed ID: 7912822
[TBL] [Abstract][Full Text] [Related]
15. Desmopressin add-on therapy for refractory nocturia in men receiving α-blockers for lower urinary tract symptoms.
Bae WJ; Bae JH; Kim SW; Chung BH; Kim JH; Kim CS; Lee HM; Lee KS; Yoo TK; Kim SI; Byun SS; Lee JY
J Urol; 2013 Jul; 190(1):180-6. PubMed ID: 23357213
[TBL] [Abstract][Full Text] [Related]
16. Prospective open label study of solifenacin for overactive bladder in children.
Bolduc S; Moore K; Nadeau G; Lebel S; Lamontagne P; Hamel M
J Urol; 2010 Oct; 184(4 Suppl):1668-73. PubMed ID: 20728124
[TBL] [Abstract][Full Text] [Related]
17. Combined use of alpha-adrenergic and muscarinic antagonists for the treatment of voiding dysfunction.
Ruggieri MR; Braverman AS; Pontari MA
J Urol; 2005 Nov; 174(5):1743-8. PubMed ID: 16217275
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of the combination of an alpha1-blocker with an anticholinergic agent in the treatment of lower urinary tract symptoms associated with bladder outlet obstruction.
Athanasopoulos A; Perimenis P
Expert Opin Pharmacother; 2005 Nov; 6(14):2429-33. PubMed ID: 16259574
[TBL] [Abstract][Full Text] [Related]
19. [Diagnostic and therapeutic value of ambulatory post-voiding bladder ultrasound imaging in evaluating neurogenic bladder dysfunction].
Amarenco G; Bayle B; Denys P; Lagauche D; Lapeyre E; Ismael SS
Presse Med; 2000 Mar; 29(8):422. PubMed ID: 10738506
[No Abstract] [Full Text] [Related]
20. The use and rationale of selective alpha blockade in children with non-neurogenic neurogenic bladder dysfunction.
Bogaert G; Beckers G; Lombaerts R
Int Braz J Urol; 2004; 30(2):128-34. PubMed ID: 15703097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
